The lack of new antibiotics will have have an effect worldwide, not least in the developing world where we are already striving to fight routine infections and infections in neglected disease areas such as Tuberculosis.
Antibiotic Action is seeking to establish international partnerships with organisations worldwide – through our combined efforts we can bring about change and ensure we make the difference that is needed.
Please support us by signing up as a partner and lending your support, or the support of your organisation to Antibiotic Action.
A joint meeting of medical societies in India was organized as a pre-conference symposium of the 2 nd annual conference of the Clinical Infectious Disease Society (CIDSCON 2012) at Chennai on 24 th August. This was a landmark event looking at how medical societies in India can work togehter to tackle the issue of resistance [...]
Antibiotics Now is the public face of the IDSA 10×20 Initiative, directly and poignently demonstrating the need for new antibiotics through the patients who needed and need them. Read more here… If you would like to share your story with Antibiotic Action please forward your contact details to firstname.lastname@example.org We will talk to you and if both [...]
Professor Piddock talks to The Times India about the need to fast track antibiotic development. Read more…..
Sharon Ladin, director of the Pew Health Group’s Antibiotics and Innovation Project, issued the following statement regarding the bipartisan, bicameral Generating Antibiotic Incentives Now (GAIN) Act, introduced today by Sen. Richard Blumenthal (D-Conn.) and Sen. Bob Corker (R-Tenn.). The bill is a companion to H.R. 2182 and contains provisions to incentivize the creation of new antibiotics [...]
The Australian Society for Infectious Diseases (ASID) and Australian Society for Antimicrobials (ASA) combined forces in February 2011 host the Summit on Antimicrobial Resistance. The Summit examined, amongst other issues, how to address the decrease in research into and the development of new, effective antibiotics and the increasing rates of multiresistant bacteria that cannot be treated with currently available antibiotics. In their website address about the conference [...]